NDC 0121-0956 – Atovaquone
Atovaquone 750 mg/5mL · Suspension · Oral
Product NDC0121-0956
Product details
- Brand name
- Atovaquone
- Generic name
- Atovaquone
- Labeler
- PAI Holdings, LLC dba PAI Pharma
- Dosage form
- Suspension
- Route
- Oral
- Marketing category
- ANDA · ANDA214272
- Marketed since
- April 4, 2025
- Listing expires
- December 31, 2027
- Pharmacologic class
- Antimalarial; Antiprotozoal
Active ingredients
- Atovaquone 750 mg/5mL
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 0121-0956-08 | 1 BOTTLE in 1 CARTON (0121-0956-08) / 210 mL in 1 BOTTLE | Apr 4, 2025 |
Other Atovaquone products
- 73141-104 Atovaquone 750 mg/5mL · Suspension · A2A Integrated Pharmaceuticals, LLC
- 42239-001 Atovaquone 750 mg/5mL · Suspension · Abon Pharmaceuticals, LLC
- 60687-534 Atovaquone 750 mg/5mL · Suspension · American Health Packaging
- 65162-693 Atovaquone 750 mg/5mL · Suspension · Amneal Pharmaceuticals LLC
- 17856-0631 Atovaquone 750 mg/5mL · Suspension · ATLANTIC BIOLOGICALS CORP.
- 17856-8631 Atovaquone 750 mg/5mL · Suspension · ATLANTIC BIOLOGICALS CORP.
- 73190-098 Atovaquone 750 mg/5mL · Suspension · AvKARE
- 50268-119 Atovaquone 750 mg/5mL · Suspension · AvPAK
- 69452-252 Atovaquone 750 mg/5mL · Suspension · Bionpharma Inc.
- 31722-629 Atovaquone 750 mg/5mL · Suspension · Camber Pharmaceuticals, Inc.
- 68999-528 Atovaquone 750 mg/5mL · Suspension · Chartwell Governmental & Specialty RX, LLC.
- 62135-528 Atovaquone 750 mg/5mL · Suspension · Chartwell RX, LLC